France's PIP implant silicone test results expected by early July
This article was originally published in Clinica
The biocompatibility tests being conducted on the fraudulent silicone that French manufacturer Poly Implant Prothèse (PIP) used in its now-banned breast implants are expected to be completed by the end of June of early July 2010, Clinica has learned.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.